- Home
- IH vs INBX Comparison
IH vs INBX Comparison
Compare IH & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- INBX
- Stock Information
- Founded
- IH 1996
- INBX 2010
- Country
- IH China
- INBX United States
- Employees
- IH N/A
- INBX N/A
- Industry
- IH Other Consumer Services
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- IH Real Estate
- INBX Health Care
- Exchange
- IH Nasdaq
- INBX Nasdaq
- Market Cap
- IH 151.5M
- INBX 178.5M
- IPO Year
- IH 2020
- INBX 2020
- Fundamental
- Price
- IH $2.98
- INBX $21.60
- Analyst Decision
- IH
- INBX Hold
- Analyst Count
- IH 0
- INBX 1
- Target Price
- IH N/A
- INBX N/A
- AVG Volume (30 Days)
- IH 64.7K
- INBX 148.3K
- Earning Date
- IH 09-26-2025
- INBX 08-12-2025
- Dividend Yield
- IH 2.88%
- INBX N/A
- EPS Growth
- IH N/A
- INBX N/A
- EPS
- IH 0.26
- INBX 111.58
- Revenue
- IH $123,701,096.00
- INBX $200,000.00
- Revenue This Year
- IH $39.02
- INBX N/A
- Revenue Next Year
- IH N/A
- INBX N/A
- P/E Ratio
- IH $11.26
- INBX $0.19
- Revenue Growth
- IH N/A
- INBX N/A
- 52 Week Low
- IH $1.47
- INBX $10.80
- 52 Week High
- IH $3.60
- INBX $25.29
- Technical
- Relative Strength Index (RSI)
- IH 58.94
- INBX 54.33
- Support Level
- IH $2.86
- INBX $20.84
- Resistance Level
- IH $3.07
- INBX $25.29
- Average True Range (ATR)
- IH 0.29
- INBX 1.84
- MACD
- IH 0.01
- INBX -0.41
- Stochastic Oscillator
- IH 55.07
- INBX 17.17
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.